11 completed, 2 terminated, 2 withdrawn, 1 unknown. 16 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 16 | Completed 11, Terminated 2, Withdrawn 2, Unknown 1 |
| Phase 2 | 6 | Completed 6 |
Follow Phobia, Social: new trials by email Literature Review of Phobia, Social trials Research Report on Phobia, Social
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline Propranolol, Prazosin - Post-traumatic Stress Disorder (PTSD) | Phase 1 | Terminated | Otsuka Pharmaceutical Development & Commercialization, Inc. | 34 | 2022-09-07 | 2024-01-23 |
| Safety, Tolerability, and Efficacy of RLS103 in Subjects With Acute Anxiety Within Social Anxiety Disorder (SAD) Low dose RLS103, High dose RLS103, placebo inhaled dry powder - Social Anxiety Disorder | Phase 1 | Withdrawn | Receptor Life Sciences | 2022-05-18 | 2024-04-02 | |
| Adaptive Treatment Strategies for Improving Engagement With a Web-Based Smoking Intervention in Socially Anxious Smokers Phase 1: Web-based intervention (MyWebQuit) with 1-way text messages, Phase 1: Web-based intervention (MyWebQuit) with interactive, 2-way text messages, Phase 2: re-engagement text messages - Social Anxiety Disorder, Tobacco Use Disorder | Phase 1 | Withdrawn | Fred Hutchinson Cancer Center | 2022-04-15 | 2021-12-08 | |
| Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers Paroxetine Hydrochloride Tablet 20 mg, Paxil® 20 mg - Major Depressive Disorder, Obsessive-Compulsive Disorder | Phase 1 | Completed | Beijing Tongren Hospital | 53 | 2018-03-29 | 2018-12-19 |
| The Modular Protocol for Mental Health (MPMH) The Modular Protocol for Mental Health, Treatment-as-usual - Major Depressive Disorder, Generalized Anxiety Disorder | Phase 1 / Phase 2 | Completed | Medical Research Council Cognition and Brain Sciences Unit | 43 | 2017-07-18 | 2020-09-29 |
| Effects of Low-Level Laser Stimulation With and Without Fear Extinction Training Extinction Training, Low-Level Laser Therapy, Sham Low-Level Laser Therapy - Phobias, Claustrophobia | Phase 1 / Phase 2 | Completed | University of Texas at Austin | 112 | 2015-08-01 | 2022-12-28 |
| Brief Behavioral Treatment for Anxiety in Young Children Parent-Led Exposure Therapy, Treatment As Usual - Obsessive-compulsive Disorder, Social Phobia | Phase 1 / Phase 2 | Completed | University of South Florida | 58 | 2014-01-01 | 2016-10-06 |
| Generalization of Extinction Learning Scopolamine, intranasal placebo - Social Anxiety Disorder | Phase 1 | Completed | University of California, Los Angeles | 60 | 2013-08-01 | 2019-10-07 |
| Bringing What Works to Youth in Corrections: A Trauma Intervention Trauma-Focused Cognitive Behavioral Therapy - Post-Traumatic Stress Disorder | Phase 1 / Phase 2 | Completed | University of Texas at Austin | 57 | 2012-11-01 | 2016-03-17 |
| Effect of Oxytocin Nasal Sprays on Social Behavior in Social Anxiety Disorder Oxytocin, Placebo - Social Anxiety Disorder | Phase 1 / Phase 2 | Completed | Stefan G. Hofmann | 60 | 2012-07-01 | 2018-02-13 |
| Treatment Study for Rural Latino Youth With Anxiety Therapist-Assisted by Telephone, Self-Help - Anxiety Disorders, Separation Anxiety Disorder | Phase 1 / Phase 2 | Completed | University of California, San Diego | 43 | 2011-11-01 | 2019-08-15 |
| Cipralex® for Anxiety Disorders in Adolescents Cipralex® - Anxiety Disorder | Phase 1 | Unknown | University of Ottawa | 30 | 2008-03-01 | 2011-02-11 |
| A Study To Evaluate The Effect Of GW876008 On The Pharmacokinetics Of Oral Contraceptive Pills GW876008, COC - Social Phobia | Phase 1 | Terminated | GlaxoSmithKline | 4 | 2007-06-08 | 2017-08-04 |
| A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety Disorder GSK561679 tablet, GW876008 tablet, alprazolam - Social Phobia | Phase 1 | Completed | GlaxoSmithKline | 35 | 2007-03-27 | 2017-08-04 |
| A Study To Compare Emotional Changes In Subjects With Social Anxiety Disorder Placebo treatment during 8 weeks, Paroxetine treatment during 8 weeks - Social Phobia | Phase 1 | Completed | GlaxoSmithKline | 56 | 2007-01-22 | 2017-07-18 |
| fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder GW679769 - Social Anxiety Disorder | Phase 1 | Completed | GlaxoSmithKline | 57 | 2006-01-01 | 2008-10-16 |
Generalized Anxiety Disorder (7) · Panic Disorder (5) · Anxiety Disorders (4) · Depressive Disorder, Major (4) · Obsessive-Compulsive Disorder (4) · Anxiety, Separation (3) · Stress Disorders, Post-Traumatic (3) · Phobia, Specific (2) · Agoraphobia (1) · Claustrophobia (1) · Depression (1) · Dysthymic Disorder (1) · Fractures, Stress (1) · Glossophobia (1)
Mental Disorders (15) · Phobic Disorders (15) · Anxiety Disorders (12) · Depressive Disorder (4) · Mood Disorders (4) · Neurodevelopmental Disorders (3) · Stress Disorders, Traumatic (3) · Trauma and Stressor Related Disorders (3) · Behavior (1) · Behavioral Symptoms (1) · Chemically-Induced Disorders (1) · Communication Disorders (1) · Fractures, Bone (1) · Language Disorders (1) · Nervous System Diseases (1)
GW 876008 (2) · Alprazolam (1) · Dexetimide (1) · Implosive Therapy (1) · Low-Level Light Therapy (1) · Mental Health (1) · NBI 77860 (1) · Oxytocin (1) · Paroxetine (1) · Prazosin (1) · Propranolol (1) · Scopolamine (1) · Therapeutics (1) · casopitant (1)
GlaxoSmithKline (4) · University of Texas at Austin (2) · Beijing Tongren Hospital (1) · Fred Hutchinson Cancer Center (1) · Medical Research Council Cognition and Brain Sciences Unit (1) · Otsuka Pharmaceutical Development & Commercialization, Inc. (1) · Receptor Life Sciences (1) · Stefan G. Hofmann (1) · University of California, Los Angeles (1) · University of California, San Diego (1) · University of Ottawa (1) · University of South Florida (1)
United States (10) · Spain (2) · United Kingdom (2) · Canada (1) · China (1)
Denise A Chavira, PhD (1) · Martine Flament, MD (1) · Michael Fanselow, Ph.D. (1) · Michael J. Telch, Ph.D. (1) · Michelle G. Craske, Ph.D. (1) · Molly M Lopez, Ph.D. (1) · Noreen Watson (1) · Tim Dalgleish, PhD (1) · Xiuli Zhao, PhD (1)
PMID 28559206, PMID 29792485, PMID 30082367, PMID 31174846, PMID 34284836
K23DA048181 (1), R34MH090149 (1), R34MH095210 (1)